Bone Biologics (BBLG) Amortization of Deferred Charges (2015 - 2018)
Bone Biologics (BBLG) reported Amortization of Deferred Charges of $1694.0 for Q3 2018, down 82.71% year-over-year from $9795.0 in Q3 2017, and down 82.71% quarter-over-quarter from $9795.0 in Q2 2018.
Bone Biologics (BBLG) Amortization of Deferred Charges (2015 - 2018) Analysis & Trends
Bone Biologics (BBLG) has 4 years of Amortization of Deferred Charges data on file, last reported at $1694.0 in Q3 2018.
- Amortization of Deferred Charges for Q3 2018 came in at $1694.0, down 82.71% year-over-year; the trailing twelve-month figure through Dec 2019 was $1694.0 (down 92.04% YoY), and the FY2018 annual result was $21283.0, down 45.67% from the prior year.
- Amortization of Deferred Charges retreated to $1694.0 in Q3 2018 per BBLG's latest filing, from $9795.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $414917.0 in Q1 2015 and troughed at $1694.0 in Q3 2018.
- A 4-year average of $51804.9 and a median of $9795.0 in 2017 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2016 and 2017: Amortization of Deferred Charges plunged 93.83% in 2016, then rose 0.02% in 2017.
- A 4-year view of Amortization of Deferred Charges shows it stood at $61836.0 in 2015, then tumbled by 84.16% to $9796.0 in 2016, then declined by 0.02% to $9794.0 in 2017, then plunged by 82.7% to $1694.0 in 2018.
- Business Quant data shows BBLG's Amortization of Deferred Charges at $1694.0 in Q3 2018, $9795.0 in Q2 2018, and $9794.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1,694.00 |
| Sep 30, 2018 | 1,694.00 |
| Jun 30, 2018 | 9,795.00 |
| Jun 30, 2018 | 9,795.00 |
| Mar 31, 2018 | 9,794.00 |
| Mar 31, 2018 | 9,794.00 |
| Dec 31, 2017 | 9,794.00 |
| Dec 31, 2017 | 9,794.00 |
| Sep 30, 2017 | 9,795.00 |
| Sep 30, 2017 | 9,795.00 |
| Jun 30, 2017 | 9,794.00 |
| Jun 30, 2017 | 9,794.00 |
| Mar 31, 2017 | 9,794.00 |
| Mar 31, 2017 | 9,794.00 |
| Dec 31, 2016 | 9,796.00 |
| Dec 31, 2016 | 9,796.00 |
| Sep 30, 2016 | 9,793.00 |
| Sep 30, 2016 | 9,793.00 |
| Jun 30, 2016 | 9,794.00 |
| Jun 30, 2016 | 9,794.00 |